Hepatopancreatobiliary Carcinoma — Trials

Hepatopancreatobiliary Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

5,150 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,360
Recruiting: 790
Ph III recruiting: 74
Growth YoY: +10.6%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (645)

clinicaltrialsPublishedShowing 101–150 of 242 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04955119	Fusion Imaging Contrast-enhanced Ultrasound LI-RADS	unknown	N/A	132	Tianjin Third Central HospitalOTHER	1	Jul 8, 2021	clinicaltrials
NCT03865875	Pilot Study of a Multimodal Prehabilitation Pancreatic Cancer Program	unknown	N/A	40	Massachusetts General HospitalOTHER	1	May 17, 2021	clinicaltrials
NCT02964260